1. Home
  2. DCOM vs ANIP Comparison

DCOM vs ANIP Comparison

Compare DCOM & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dime Community Bancshares Inc.

DCOM

Dime Community Bancshares Inc.

HOLD

Current Price

$39.24

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$82.29

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCOM
ANIP
Founded
1864
2001
Country
United States
United States
Employees
902
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
DCOM
ANIP
Price
$39.24
$82.29
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$37.80
$110.00
AVG Volume (30 Days)
214.3K
274.3K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
2.81%
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
$21.40
$21.01
Revenue Next Year
$12.65
$17.59
P/E Ratio
$14.81
$63.81
Revenue Growth
N/A
2.47
52 Week Low
$25.63
$62.61
52 Week High
$40.53
$99.50

Technical Indicators

Market Signals
Indicator
DCOM
ANIP
Relative Strength Index (RSI) 61.30 58.41
Support Level $34.86 $76.73
Resistance Level N/A $83.61
Average True Range (ATR) 0.86 2.27
MACD 0.21 0.36
Stochastic Oscillator 65.09 89.81

Price Performance

Historical Comparison
DCOM
ANIP

About DCOM Dime Community Bancshares Inc.

Dime Community Bancshares Inc operates as a holding company. The company gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, and mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: